PP
NEOS

Paloma Partners’s Neos Therapeutics, Inc NEOS Stock Holding History

Paloma Partners’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-107,524
Closed -$159K – 2636
2019
Q3 		$159K Sell
107,524
-105,676
-50% -$171K ﹤0.01% 1788
2019
Q2 		$275K Buy
+213,200
New +$392K ﹤0.01% 1350
2018
Q2 		– Sell
-13,208
Closed -$110K – 2381
2018
Q1 		$110K Buy
13,208
+987
+8% +$9.42K ﹤0.01% 1838
2017
Q4 		$125K Buy
+12,221
New +$117K ﹤0.01% 1781

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Paloma Partners's NEOS Position: Q4 2019 in Review

Paloma Partners sold out of Neos Therapeutics, Inc (NEOS) in Q4 2019, closing a stake of 107,524 shares — an estimated $159K sold.

Paloma Partners first reported a position in NEOS in Q4 2017 and held it in 4 quarters. The position peaked at $275K in Q2 2019. 54 funds tracked by Wall St. Rank hold NEOS as of Q4 2019.

  • Paloma Partners reported no remaining Neos Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • Paloma Partners sold 107,524 Neos Therapeutics, Inc shares in Q4 2019, an estimated $159K.
  • Paloma Partners first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 4 quarters.
  • Paloma Partners's Neos Therapeutics, Inc position peaked at $275K in Q2 2019.
  • 54 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.